[RGLS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -2.70%
YoY- 12.62%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,012 -7,139 -6,795 -7,551 -7,258 -6,718 -7,133 -1.13%
Tax 1 -45 1 -12 83 1 214 -97.23%
NP -7,013 -7,094 -6,796 -7,539 -7,341 -6,719 -7,133 -1.12%
Tax Rate - - - - - - - -
Total Cost 7,013 7,094 6,796 7,539 7,341 6,719 7,133 -1.12%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.37 -0.42 -0.40 -0.50 -0.50 -0.46 -0.67 -32.76%
EPS Diluted -0.37 -0.42 -0.40 -0.50 -0.50 -0.46 -0.67 -32.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.